Clincosm LogoSign in Get a demo

type2diabetes

Showing 1 - 25 of 62
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Blood Glucose Variability in Type 2 Diabetes Mellitus and

Recruiting
  • COVID-19 Pneumonia
  • Type2diabetes
  • Glucose variability
  • Jinan, Shandong, China
    Qilu hospital of shandong university
Nov 24, 2023

Type2diabetes, Obesity, Diet, Healthy Trial in Milano (Vegetarian Meal)

Recruiting
  • Type2diabetes
  • +3 more
  • Vegetarian Meal
  • Milano, Italy
    IRCCS Ospedale San Raffaele
Nov 28, 2023

Type2diabetes Trial in Çankaya (Upper extremity aerobic exercise training, Control Group)

Not yet recruiting
  • Type2diabetes
  • Upper extremity aerobic exercise training
  • Control Group
  • Çankaya, Ankara, Turkey
    Gazi University, Faculty of Health Sciences, Department of Physi
Nov 13, 2023

Type2diabetes Trial in Nasiriyah, Basrah (Insulin Glargine 100 UNT/ML Pen Injector [Lantus], Saxagliptin 2.5 mg/ Metformin

Not yet recruiting
  • Type2diabetes
  • Insulin Glargine 100 UNT/ML Pen Injector [Lantus]
  • +2 more
  • Nasiriyah, Thi Qar, Iraq
  • +1 more
Oct 28, 2023

Type2diabetes, PreDiabetes, Renal Failure Trial in Duesseldorf, Heidelberg (Dapagliflozin (Forxiga®), Placebo matching

Not yet recruiting
  • Type2diabetes
  • +2 more
  • Dapagliflozin (Forxiga®)
  • +2 more
  • Duesseldorf, Germany
  • +1 more
Sep 18, 2023

Postural Control, Ankle and Trunk Proprioception in Type 2

Not yet recruiting
  • Type2diabetes
  • Semmes Weinstein Monofilament Test
  • +5 more
  • (no location specified)
Sep 17, 2023

Comorbidities Resolution After MGB Surgery and Change in Body

Not yet recruiting
  • Morbid Obesity
  • +7 more
  • Mini gastric bypass surgery
  • (no location specified)
Aug 28, 2023

Pharmacist-led, Collaborative Practice on Clinical Outcomes in

Active, not recruiting
  • Diabetes
  • Type2diabetes
  • Chart Review
  • Dallas, Texas
    Methodist Dallas Medical Center
Aug 9, 2023

Susceptibility to Infectious Diseases in Obesity

Recruiting
  • Obesity
  • +3 more
  • Observational
  • Novara, Italy
    Maggiore della Carità Hospital
Aug 2, 2023

Mitochondrial Substrate Utilization in the Diabetic Human Heart

Recruiting
  • Heart Failure
  • +4 more
    • Düsseldorf, Germany
      University-Hospital Düsseldorf Division of Cardiology, Pulmonary
    Jul 14, 2023

    SGLT-2 Inhibitors in T2DM and Moderate to Severe Liver Fibrosis

    Completed
    • Type2diabetes
      • New Delhi, Delhi, India
        Fortis CDOC Hospital
      Jul 14, 2023

      Type2diabetes, Pregnancy Related, Continuous Glucose Monitoring Trial in Beijing (Real-time Continuous Glucose Monitoring

      Recruiting
      • Type2diabetes
      • +4 more
      • Real-time Continuous Glucose Monitoring System
      • Beijing, Beijing, China
        Peking University Third Hospital
      Jul 8, 2023

      Xanthelasma With Atherosclerosis, Hepatic Fat and Fibrosis

      Recruiting
      • Type2diabetes
      • Clinical Examination
      • Delhi, India
        Fortis CDOC Hospital
      Jul 11, 2023

      Non-Alcoholic Fatty Liver Disease, Type2diabetes Trial in Karachi (Empagliflozin 10 MG, Pioglitazone 15mg, Metformin)

      Not yet recruiting
      • Non-Alcoholic Fatty Liver Disease
      • Type2diabetes
      • Empagliflozin 10 MG
      • +2 more
      • Karachi, Sindh, Pakistan
        Medical ICU, Jinnah Postgraduate Medical Centre
      Jul 11, 2023

      Use of AI in Cardiometabolic Risk Prediction in Asian Indians

      Recruiting
      • Type2diabetes
      • Medical and Clinical History
      • New Delhi, Delhi, India
        Fortis Cdoc Hospital
      Jul 11, 2023

      Type2diabetes Trial in New Delhi (Metformin)

      Completed
      • Type2diabetes
      • New Delhi, Delhi, India
        Anoop misra
      Jul 11, 2023

      Type2diabetes Trial in Cleveland (Prompt-sheet, Usual education)

      Not yet recruiting
      • Type2diabetes
      • Prompt-sheet
      • Usual education
      • Cleveland, Ohio
        University Hospitals Cleveland Medical Center
      Jul 10, 2023

      Assessment of Hand Grip Strength Using Jamar Dynamometer

      Recruiting
      • Type2diabetes
      • Using Jamar Dynamometer for Grip Strength.
      • Delhi, India
        Fortis CDOC Hospital
      Jul 10, 2023

      Pre-Gestational Diabetes, Type2diabetes, Pregnancy in Diabetic Trial in Columbus (Immediate inpatient postpartum OGTT, Standard

      Not yet recruiting
      • Pre-Gestational Diabetes
      • +5 more
      • Immediate inpatient postpartum OGTT
      • Standard of care 4-12 week postpartum OGTT
      • Columbus, Ohio
        The Ohio State University Wexner Medical Center OB/GYN Maternal
      Jun 9, 2023

      Heart Failure in a High-Risk Diabetic Cohort

      Recruiting
      • Type2diabetes
      • heart failure risk factors
      • Taipei, Taiwan
        Mackay Memorial Hospital
      May 17, 2023

      Obesity, Type2diabetes, Bariatric Surgery Candidate Trial in Lisboa (Roux-en-Y gastric By-pass (RYGB) surgery, Bariatric

      Recruiting
      • Obesity
      • +3 more
      • Roux-en-Y gastric By-pass (RYGB) surgery
      • Bariatric Arterial Embolization (BAE) procedure
      • Lisboa, Portugal
        Cruz Vermelha Hospital
      May 15, 2023

      Obesity, Childhood, Type2diabetes Trial (Bennett Kids PowerUP Project)

      Not yet recruiting
      • Obesity, Childhood
      • Type2diabetes
      • Bennett Kids PowerUP Project
      • (no location specified)
      May 4, 2023

      Type2diabetes, Endothelial Dysfunction Trial in Malmö (C21)

      Recruiting
      • Type2diabetes
      • Endothelial Dysfunction
      • Malmö, Sweden
        Skånes universitetssjukhus
      Apr 25, 2023

      Type2diabetes, Type 2 Diabetes Treated With Insulin Trial (Low-fat, vegan diet)

      Not yet recruiting
      • Type2diabetes
      • Type 2 Diabetes Treated With Insulin
      • Low-fat, vegan diet
      • (no location specified)
      Mar 20, 2023

      Type2diabetes, Diabetic Kidney Disease Trial (Investigational Product - MIB 626, Placebo)

      Not yet recruiting
      • Type2diabetes
      • Diabetic Kidney Disease
      • Investigational Product - MIB 626
      • Placebo
      • (no location specified)
      Mar 6, 2023